Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWOU
3151
DELISTED
2U Inc
TWOU
| $492K | ﹤0.01% |
429
-1,655
| -79% | -$2.1M |
|
|
ORC
3152
Orchid Island Capital
ORC
$1.3B
| $491K | ﹤0.01% |
16,373
+11,871
| +264% | +$333K |
|
3153
Carriage Services
CSV
$641M
| $490K | ﹤0.01% |
13,938
-580
| -4% | -$20.1K |
|
3154
Luxfer Holdings
LXFR
$456M
| $490K | ﹤0.01% |
22,997
+14,118
| +159% | +$266K |
|
3155
PUT
Pan American Silver
PAAS
$18.2B
| $489K | ﹤0.01% |
16,300
-21,000
| -56% | -$682K |
|
3156
Grupo Cibest SA
CIB
$22B
| $488K | ﹤0.01% |
15,270
-50,450
| -77% | -$1.79M |
|
3157
National Fuel Gas
NFG
$7.82B
| $487K | ﹤0.01% |
9,732
-32,472
| -77% | -$1.47M |
|
3158
OneSpaWorld
OSW
$2.61B
| $487K | ﹤0.01% |
45,632
+29,092
| +176% | +$294K |
|
3159
Tredegar Corp
TG
$265M
| $487K | ﹤0.01% |
32,476
+3,778
| +13% | +$60.5K |
|
3160
UNIFI
UFI
$119M
| $487K | ﹤0.01% |
17,637
+1,467
| +9% | +$35.4K |
|
3161
CALL
Eli Lilly
LLY
$1.02T
| $486K | ﹤0.01% |
2,600
-28,500
| -92% | -$5.57M |
|
|
PRTK
3162
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $486K | ﹤0.01% |
68,910
+22,450
| +48% | +$162K |
|
|
SMAR
3163
DELISTED
Smartsheet Inc.
SMAR
| $485K | ﹤0.01% |
7,591
+4,110
| +118% | +$288K |
|
3164
FTI Consulting
FCN
$4.4B
| $480K | ﹤0.01% |
3,431
-2,131
| -38% | -$252K |
|
3165
Quince Therapeutics
QNCX
$22.9M
| $480K | ﹤0.01% |
67
+40
| +148% | +$288K |
|
|
CMRX
3166
DELISTED
Chimerix, Inc.
CMRX
| $480K | ﹤0.01% |
49,925
+34,125
| +216% | +$313K |
|
|
DSPG
3167
DELISTED
DSP Group Inc
DSPG
| $480K | ﹤0.01% |
33,681
-19,169
| -36% | -$306K |
|
3168
Orrstown Financial Services
ORRF
$840M
| $478K | ﹤0.01% |
21,438
+2,380
| +12% | +$47.3K |
|
|
PCSB
3169
DELISTED
PCSB Financial Corporation
PCSB
| $477K | ﹤0.01% |
28,766
+6,038
| +27% | +$99K |
|
3170
Uranium Energy
UEC
$4.75B
| $475K | ﹤0.01% |
166,198
+102,572
| +161% | +$224K |
|
|
VBIV
3171
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $475K | ﹤0.01% |
5,090
+2,924
| +135% | +$296K |
|
|
ATNX
3172
DELISTED
Athenex, Inc. Common Stock
ATNX
| $475K | ﹤0.01% |
5,522
+1,751
| +46% | +$336K |
|
3173
BlackRock Science and Technology Term Trust
BSTZ
$1.95B
| $473K | ﹤0.01% |
+12,400
| New | +$452K |
|
3174
Crawford & Co Class A
CRD.A
$532M
| $473K | ﹤0.01% |
44,450
+39,203
| +747% | +$356K |
|
3175
PUT
Kimberly-Clark
KMB
$36.3B
| $473K | ﹤0.01% |
3,400
-283,400
| -99% | -$37.6M |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.